Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Clin Microbiol Infect. 2016 Feb 3;22(6):513–519. doi: 10.1016/j.cmi.2016.01.023

Table 2. Outcomes.

All data expressed as n (%), unless otherwise indicated. IQR, interquartile range.

controls BSI p# pneumonia p# UTI p#
n 223 90 49 121
Length of stay, days, median (IQR) 9 (5–16) 14 (9–24) <0.01 19 (10–30) <0.0001 10 (6–17) 0.76
Post-culture length of stay, days, median (IQR) 7 (4–12) 9 (4–16) 0.03 10 (6–17) <0.01 7 (4–12) 0.30
Critical illness§ 49 (22) 50 (56) <0.0001 42 (86) <0.0001 33 (27) 0.29
Disposition* <0.0001 <0.0001 0.59
 Death 21 (9) 34 (38) 17 (34) 9 (7)
 Hospice 5 (2) 1 (1) 2 (4) 2 (2)
 Alive 197 (88) 55 (61) 30 (61) 110 (91)
##

time from admission to first positive culture in days.

#

comparison with controls.

§

critical illness defined as Pitt bacteremia score ≥4 at the time of index culture.

*

comparison between death/hospice and alive.